Allworth Financial
SION icon

Allworth Financial’s Sionna Therapeutics SION Stock Holding History

Allworth Financial’s Portfolio SION Stock Details SION Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.01K Buy
23
+22
+2,200% +$505 ﹤0.01% 4830
2026
Q2 		$44 Sell
1
-28
-97% -$1.12K ﹤0.01% 5073
2026
Q1 		$1.16K Buy
29
+1
+4% +$38 ﹤0.01% 4524
2025
Q4 		$1.15K Buy
28
+6
+27% +$228 ﹤0.01% 4321
2025
Q3 		$648 Buy
+22
New +$479 ﹤0.01% 4372

Other funds holding SION

Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Allworth Financial's SION Position: Q3 2026 in Review

Allworth Financial increased its Sionna Therapeutics (SION) stake by 2,200% in Q3 2026, buying an estimated $505 and bringing the position to 23 shares worth $1.01K. The position accounts for ﹤0.01% of the portfolio, ranked #4830.

Allworth Financial first reported a position in SION in Q3 2025 and has held it in 5 quarters since. The position peaked at $1.16K in Q1 2026. 45 funds tracked by Wall St. Rank hold SION as of Q3 2026.

  • Allworth Financial held 23 shares of Sionna Therapeutics worth $1.01K as of Q3 2026.
  • Allworth Financial bought 22 Sionna Therapeutics shares in Q3 2026, an estimated $505.
  • Sionna Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #4830 holding.
  • Allworth Financial first reported a position in Sionna Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Allworth Financial's Sionna Therapeutics position peaked at $1.16K in Q1 2026.
  • 45 funds tracked by Wall St. Rank held Sionna Therapeutics as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.